Generic APIs
We supplies peptide APIs for the treatments of Multiple Sclerosis, GTH, Diabetes Type I/II, Insipidus, female diseases (Endometriosis, Uterine Fibroids, Premature Ovulation), giving birth, Blood Clots, Cancers, etc.
Our 3 APIs are going to submit the USDMF, we provide the service of joint declaration and commercialize the APIs.
| Product Name | CAS No. | Product Name | CAS No. |
| Octreotide Acetate | 79517-01-4 | Salcitonin Acetate | 47931-85-1 |
| Leuprorelin Acetate | 74381-53-6 | Glucagon | 16941-35-2 |
| Glatiramer Acetate | 147245-92-9 | Pramlintide | 196078-30-5 |
| Bivalirudin | 128270-60-0 | Alarelin acetate | 79561-22-1 |
| Triptorelin Acetate | 57773-63-4 | Deslorelin | 57773-65-6 |
| Terlipressin Acetate | 52232-67-4 | Aviptadil Acetate | 40077-57-4 |
| Desmopressin Acetate | 16679-58-6 | Antide Acetate | 112568-12-4 |
| Exenatide Acetate | 141732-76-5 | Protirelin | 24305-27-9 |
| Carbetocin Acetate | 37025-55-1 | Angiotensin Acetate | 20071-00-5 |
| Teriparatide Acetate | 52232-67-4 | Argpressin Acetate | 113-79-1 |
| Eptifibatide Acetate | 148031-34-9 | Elcatonin Acetate | 60731-46-6 |
| Ipamorelin | 170851-70-4 | Eledoisin Acetate | 69-25-0 |
| Atosiban Acetate | 90779-69-4 | Enfuvirtide Acetate | 159519-65-0 |
| Liraglutide | 204656-20-2 | Lysipressin Acetate | 50-57-7 |
| Linaclotide | 851199-59-2 | Secretin Acetate | 17034-35-4 |
| Thymalfasin | 69440-99-9 | Somatostatin Acetate | 38916-34-6 |
| Degarelix Acetate | 214766-78-6 | Tetracosactide Acetate | 16960-16-0 |
| ganirelix Acetate | 129311-55-3 | Vapreotide Acetate | 103222-11-3 |
| Sincalide | 25126-32-3 | Abarelix Acetate | 183552-38-7 |
| Thymopentin | 69558-55-0 | Gonadorelin | 33515-09-2 |
| Deslorelin Acetate | 57773-65-6 | Oxytocin Acetate | 50-56-6 |
| Cetrorelix Acetate | 120287-85-6 | Icatibant | 130308-48-4 |
| Pasireotide | 396091-73-9 | Lanreotide | 108736-35-2 |
| Ziconotide | 107452-89-1 | Thymosin α1 | 62304-98-7 |
| Goserelin Acetate | 145781-92-6 |
-
Lysipressin Acetate
Product Name Lysipressin Acetate Cas No. 50-57-7 Sequence Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2(Cys&Cys Bridge) Molecular Formula C46H65N13O12S2 Molar Mass 1056.22 g/mol Purity ≥98% Impurity ≤0.5% Storage Temperature 2-8℃ Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Applicant field: Lypressin is indicated for the prevention or control of polydipsia, polyuria, and dehydration associated with central diabetes insipidus caused by insufficient antidiuretic hormone.
-
Enfuvirtide Acetate
Product Name:Enfuvirtide Acetate Cas No. :159519-65-0 Sequence :AC-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2 Molecular Formula :C204H301N51O64 Molar Mass :4492.1 g/mol Purity :≥98% Impurity :≤0.5% Storage Temperature 2-8℃ Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Application field: Enfuvirtide Acetate is a synthetic peptide HIV fusion inhibitor, it can be combined with the viral envelope glycoprotein to prevent the virus and cell membrane fusion necessary for the conformational changes, thereby inhibiting HIV-1 replication.
-
Leuprorelin Acetate
Product Name Leuprorelin Acetate; Cas No. 74381-53-6; Sequence Glp-His-Trp-Ser-Tyr-DLeu-Leu-Arg-Pro-NHEt; Molecular Formula C59H84N16O12; Molar Mass 1209.4 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Leuprorelin Acetate is for the treatments of Endometriosis; uterine fibroids with menorrhagia, lower abdominal pain, low back pain and anemia; premenopausal breast cancer, and estrogen receptor-positive patients; prostate cancer; central precocious puberty. Clinical mainly for prostate cancer and endometriosis.
-
Glatiramer Acetate
Product Name Glatiramer Acetate; Cas No. 147245-92-9; Sequence (Glu, Ala, Lys, Tyr)x•xCH3COOH; Molecular Formula : C25H45N5O13; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Glatiramer Acetate is mainly used for multiple sclerosis. It is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability. While a conclusive diagnosis of multiple sclerosis requires a history of two or more episodes of symptoms and signs, glatiramer acetate is approved to treat a first episode anticipating a diagnosis. It is also used to treat relapsing-remitting multiple sclerosis. It is administered by subcutaneous injection.
-
Bivalirudin
Product Name Bivalirudin; Cas No. 128270-60-0 Sequence D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH; Molecular Formula C98H138N24O33; Molar Mass 2180.29 g/mol; Molecular Weight: 2180.29 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Bivalirudin is mainly used to prevent angioplasty interventional treatment of unstable angina, before and after the ischemic complications.
-
Triptorelin Acetate
Product Name Triptorelin Acetate; Cas No. 57773-63-4; Sequence Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2; Molecular Formula C64H82N18O13; Molar Mass 1311.5 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Triptorelin Acetate is as an anticoagulant for adult elective percutaneous coronary intervention (PCI)
-
Terlipressin Acetate
Product Name Terlipressin Acetate; Cas No. 14636-12-5; Sequence H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2（Cys and Cys bridge）; Molecular Formula C52H74N16O15S2; Molar Mass 1227.37 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Terlipressin Acetate is an analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help.Indications for use include norepinephrine-resistant septic shock and hepatorenal syndrome. In addition, it is used to treat bleeding esophageal varices.
-
Lixisenatide Acetate
Product Name: Lixisenatide Acetate; Cas No.: 827033-10-3 Sequence: H–His–Gly–Glu–Gly–Thr–Phe–Thr–Ser–Asp–Leu–Ser–Lys–Gln–Met–Glu–Glu–Glu–Ala–Val–Arg–Leu–Phe–Ile–Glu–Trp–Leu–Lys–Asn–Gly–Gly–Pro–Ser–Ser–Gly–Ala–Pro–Pro–Ser–Lys–Lys–Lys–Lys–Lys–Lys–Nh2 Molecular Formula: C215H347N61O65S Molecular Weight: 4858.49 Purity: ≥98%; Impurity: ≤0.5% ; Storage Temperature; -20℃ Packing Size: 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqiremen
-
Abaloparatide
Full Name：Abaloparatide
CAS No.: 247062-33-5
Sequence: H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Leu-Aib-Lys-Leu-His-Thr-Ala-NH2
Formular: C174H300N56O49
Molecular Weight: 3960.657 g/mol
Purity：≥98.0%
Impurity ≤0.5% ;
Storage Temperature 2-8℃;
Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement.
Abaloparatide, which has less effect on osteoclasts, is an alternative to teriparatide in patients with postmenopausal osteoporosis who are at high risk for fractures or who have failed antiresorptive therapy based on initial clinical studies and economic modeling.Abaloparatide is an analog of PTHrP (parathyroid hormone-related protein). It was approved in April 28, 2017 by the FDA (as Tymlos) for the treatment of postmenopausal women with osteoporosis at high risk for fracture. Abaloparatide is a synthetic peptide that is related to hPTHrP and has demonstrated in preclinical testing the potential to widen the anabolic window for bone therapeutics, stimulating bone formation with a limited effect on bone resorption and mineral mobilization. This could enable improved convenience over currently available anabolic therapies, resulting in greater compliance and, ultimately, greater benefit to patients.
-
Dalargin
Product Name: Dalargin Cas NO. 81733-79-1 Synonyms: Dalergin; Wound Healing Peptide; Sequence: H-Tyr-D-Ala-Gly-Phe-Leu-Arg-OH Molecular Formula: C35H51N9O8 Formula Weight: 725.83 Purity ≥98%; Impurity ≤0.5% ; Storage Temperature -15℃ Packing Size 1G/Bottle, 10G/Bottle,100G/Bottle or at customers reqirement.
